vs
南玻集团(CSGS)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
南玻集团的季度营收约是REPLIGEN CORP的1.6倍($323.1M vs $197.9M),REPLIGEN CORP净利率更高(6.7% vs 2.2%,领先4.5%),REPLIGEN CORP同比增速更快(13.6% vs 2.0%),南玻集团自由现金流更多($55.8M vs $17.6M),过去两年REPLIGEN CORP的营收复合增速更高(14.4% vs 4.6%)
中国南玻集团股份有限公司是中国规模最大的建筑玻璃生产商,业务涵盖浮法玻璃、建筑玻璃、显示玻璃、汽车玻璃、镀膜玻璃、镜子、彩滤玻璃、太阳能玻璃及节能玻璃等各类玻璃产品的研发、生产与销售,产品广泛应用于建筑、消费电子、新能源汽车、光伏等多个领域。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
CSGS vs RGEN — 直观对比
营收规模更大
CSGS
是对方的1.6倍
$197.9M
营收增速更快
RGEN
高出11.6%
2.0%
净利率更高
RGEN
高出4.5%
2.2%
自由现金流更多
CSGS
多$38.3M
$17.6M
两年增速更快
RGEN
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $323.1M | $197.9M |
| 净利润 | $7.0M | $13.3M |
| 毛利率 | 50.0% | 52.5% |
| 营业利润率 | 9.0% | 9.0% |
| 净利率 | 2.2% | 6.7% |
| 营收同比 | 2.0% | 13.6% |
| 净利润同比 | -79.7% | 143.9% |
| 每股收益(稀释后) | $0.24 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CSGS
RGEN
| Q4 25 | $323.1M | $197.9M | ||
| Q3 25 | $303.6M | $188.8M | ||
| Q2 25 | $297.1M | $182.4M | ||
| Q1 25 | $299.5M | $169.2M | ||
| Q4 24 | $316.7M | $174.1M | ||
| Q3 24 | $295.1M | $154.9M | ||
| Q2 24 | $290.3M | $154.1M | ||
| Q1 24 | $295.1M | $151.3M |
净利润
CSGS
RGEN
| Q4 25 | $7.0M | $13.3M | ||
| Q3 25 | $20.5M | $14.9M | ||
| Q2 25 | $12.3M | $14.9M | ||
| Q1 25 | $16.1M | $5.8M | ||
| Q4 24 | $34.5M | $-30.3M | ||
| Q3 24 | $19.1M | $-654.0K | ||
| Q2 24 | $13.8M | $3.3M | ||
| Q1 24 | $19.5M | $2.1M |
毛利率
CSGS
RGEN
| Q4 25 | 50.0% | 52.5% | ||
| Q3 25 | 48.1% | 53.2% | ||
| Q2 25 | 49.5% | 50.0% | ||
| Q1 25 | 48.4% | 53.6% | ||
| Q4 24 | 51.3% | 26.1% | ||
| Q3 24 | 49.4% | 50.0% | ||
| Q2 24 | 47.3% | 49.8% | ||
| Q1 24 | 46.5% | 49.5% |
营业利润率
CSGS
RGEN
| Q4 25 | 9.0% | 9.0% | ||
| Q3 25 | 10.0% | 8.9% | ||
| Q2 25 | 10.0% | 7.6% | ||
| Q1 25 | 9.8% | 3.9% | ||
| Q4 24 | 13.4% | -17.7% | ||
| Q3 24 | 10.8% | -5.1% | ||
| Q2 24 | 8.8% | 1.0% | ||
| Q1 24 | 10.8% | 1.3% |
净利率
CSGS
RGEN
| Q4 25 | 2.2% | 6.7% | ||
| Q3 25 | 6.7% | 7.9% | ||
| Q2 25 | 4.1% | 8.2% | ||
| Q1 25 | 5.4% | 3.4% | ||
| Q4 24 | 10.9% | -17.4% | ||
| Q3 24 | 6.5% | -0.4% | ||
| Q2 24 | 4.8% | 2.2% | ||
| Q1 24 | 6.6% | 1.4% |
每股收益(稀释后)
CSGS
RGEN
| Q4 25 | $0.24 | $0.24 | ||
| Q3 25 | $0.73 | $0.26 | ||
| Q2 25 | $0.44 | $0.26 | ||
| Q1 25 | $0.57 | $0.10 | ||
| Q4 24 | $1.20 | $-0.55 | ||
| Q3 24 | $0.67 | $-0.01 | ||
| Q2 24 | $0.48 | $0.06 | ||
| Q1 24 | $0.68 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $180.0M | $767.6M |
| 总债务越低越好 | $539.5M | $542.2M |
| 股东权益账面价值 | $283.7M | $2.1B |
| 总资产 | $1.5B | $2.9B |
| 负债/权益比越低杠杆越低 | 1.90× | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
CSGS
RGEN
| Q4 25 | $180.0M | $767.6M | ||
| Q3 25 | $158.4M | $748.7M | ||
| Q2 25 | $145.9M | $708.9M | ||
| Q1 25 | $136.0M | $697.2M | ||
| Q4 24 | $161.8M | $757.4M | ||
| Q3 24 | $118.4M | $784.0M | ||
| Q2 24 | $110.4M | $809.1M | ||
| Q1 24 | $120.8M | $780.6M |
总债务
CSGS
RGEN
| Q4 25 | $539.5M | $542.2M | ||
| Q3 25 | $538.6M | $537.9M | ||
| Q2 25 | $537.8M | — | ||
| Q1 25 | $537.6M | — | ||
| Q4 24 | $538.5M | $525.6M | ||
| Q3 24 | $539.5M | — | ||
| Q2 24 | $540.5M | — | ||
| Q1 24 | $541.5M | — |
股东权益
CSGS
RGEN
| Q4 25 | $283.7M | $2.1B | ||
| Q3 25 | $289.5M | $2.1B | ||
| Q2 25 | $290.7M | $2.1B | ||
| Q1 25 | $283.1M | $2.0B | ||
| Q4 24 | $282.6M | $2.0B | ||
| Q3 24 | $288.4M | $2.0B | ||
| Q2 24 | $273.3M | $2.0B | ||
| Q1 24 | $269.3M | $2.0B |
总资产
CSGS
RGEN
| Q4 25 | $1.5B | $2.9B | ||
| Q3 25 | $1.5B | $2.9B | ||
| Q2 25 | $1.4B | $2.9B | ||
| Q1 25 | $1.4B | $2.9B | ||
| Q4 24 | $1.5B | $2.8B | ||
| Q3 24 | $1.4B | $2.8B | ||
| Q2 24 | $1.4B | $2.9B | ||
| Q1 24 | $1.3B | $2.8B |
负债/权益比
CSGS
RGEN
| Q4 25 | 1.90× | 0.26× | ||
| Q3 25 | 1.86× | 0.26× | ||
| Q2 25 | 1.85× | — | ||
| Q1 25 | 1.90× | — | ||
| Q4 24 | 1.91× | 0.27× | ||
| Q3 24 | 1.87× | — | ||
| Q2 24 | 1.98× | — | ||
| Q1 24 | 2.01× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $59.2M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $55.8M | $17.6M |
| 自由现金流率自由现金流/营收 | 17.3% | 8.9% |
| 资本支出强度资本支出/营收 | 1.1% | 4.1% |
| 现金转化率经营现金流/净利润 | 8.46× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $141.4M | $93.9M |
8季度趋势,按日历期对齐
经营现金流
CSGS
RGEN
| Q4 25 | $59.2M | $25.7M | ||
| Q3 25 | $47.9M | $48.1M | ||
| Q2 25 | $37.3M | $28.6M | ||
| Q1 25 | $11.5M | $15.0M | ||
| Q4 24 | $82.5M | $39.2M | ||
| Q3 24 | $39.5M | $49.3M | ||
| Q2 24 | $43.1M | $42.2M | ||
| Q1 24 | $-29.4M | $44.7M |
自由现金流
CSGS
RGEN
| Q4 25 | $55.8M | $17.6M | ||
| Q3 25 | $43.9M | $43.4M | ||
| Q2 25 | $34.6M | $21.5M | ||
| Q1 25 | $7.1M | $11.4M | ||
| Q4 24 | $76.6M | $33.6M | ||
| Q3 24 | $32.0M | $42.3M | ||
| Q2 24 | $38.8M | $37.4M | ||
| Q1 24 | $-34.1M | $36.4M |
自由现金流率
CSGS
RGEN
| Q4 25 | 17.3% | 8.9% | ||
| Q3 25 | 14.5% | 23.0% | ||
| Q2 25 | 11.6% | 11.8% | ||
| Q1 25 | 2.4% | 6.8% | ||
| Q4 24 | 24.2% | 19.3% | ||
| Q3 24 | 10.8% | 27.3% | ||
| Q2 24 | 13.4% | 24.3% | ||
| Q1 24 | -11.6% | 24.0% |
资本支出强度
CSGS
RGEN
| Q4 25 | 1.1% | 4.1% | ||
| Q3 25 | 1.3% | 2.5% | ||
| Q2 25 | 0.9% | 3.9% | ||
| Q1 25 | 1.5% | 2.1% | ||
| Q4 24 | 1.9% | 3.2% | ||
| Q3 24 | 2.5% | 4.5% | ||
| Q2 24 | 1.5% | 3.1% | ||
| Q1 24 | 1.6% | 5.5% |
现金转化率
CSGS
RGEN
| Q4 25 | 8.46× | 1.93× | ||
| Q3 25 | 2.34× | 3.23× | ||
| Q2 25 | 3.04× | 1.92× | ||
| Q1 25 | 0.71× | 2.57× | ||
| Q4 24 | 2.39× | — | ||
| Q3 24 | 2.07× | — | ||
| Q2 24 | 3.12× | 12.70× | ||
| Q1 24 | -1.51× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSGS
| Software As A Service And Related Solutions | $287.2M | 89% |
| License And Service | $22.6M | 7% |
| Maintenance | $13.3M | 4% |
RGEN
暂无分部数据